Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law Everyone online is suddenly injecting peptides. But almost nobody understands the scienceor the regulation. The FDA recently shifted several peptides off the Category 2 safety risk list tied to compounding rules. First, that BPC 157 FDA Approval Status 2026: RFK Jr, Advisory Committee & Reclassification FDA to Convene Expert Panel on Expanding Access to Peptides Amid Safety, Regulatory Debate AJMC FDA Issues Warning: Compounding Certain Bulk Drug Substances May Pose Major Legal and Patient Safety Risks Lengea FDA's Overreach on Compounded Peptides